NCT01557296

Brief Summary

The objective of the study is in subjects with Insulin Treated Diabetes Mellitus type 1 or 2 and gastroparesis:

  • validate radiopaque markers with fluoroscopy with gastric scintigraphy method
  • study the difference of metabolic control including the frequents of hypoglycaemia, gastrointestinal symptoms, quality of life and nutrition state during dietary treatment of food of small particle size compared with food of large particle size
  • validate the radiopaque markers method and measurement of the blood glucose and gastrointestinal symptoms after a test meal, against the gastric scintigraphy
  • determine if the function of gastric emptying can be improved after intervention

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Sep 2007

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

March 16, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 19, 2012

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

6.5 years

First QC Date

March 16, 2012

Last Update Submit

November 5, 2018

Conditions

Keywords

DietDietary treatmentParticle sizeGastroparesisDiabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Metabolic Control - HbA1c

    22 weeks

Secondary Outcomes (1)

  • gastrointestinal symptoms - Questionnaire: Patient Assessment of upper Gastrointestinal Disorders Symptoms, Gastrointestinal Symptom Rating Scale

    22 weeks

Study Arms (2)

Diabetic diet

PLACEBO COMPARATOR

Control group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.

Dietary Supplement: dietary treatment: food of small particle sizeRadiation: Validate X-ray diagnostic method.Other: Can the motility be improvedBiological: postprandial plasma glucose

Diet food in small particle size

ACTIVE COMPARATOR

Intervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.

Dietary Supplement: dietary treatment: food of small particle sizeRadiation: Validate X-ray diagnostic method.Other: Can the motility be improvedBiological: postprandial plasma glucose

Interventions

Subjects with diabetes mellitus and gastroparesis. Insulin treatment. Dietary treatment with food of small particle size.

Also known as: Randomized study, Diabetic gastroparesis, Dietary treatment:Food of small particle size, Metabolic control, Gastrointestinal symptoms, Quality of life, Nutrition status, Autonomic neuropathy
Diabetic dietDiet food in small particle size

Follow 20 radiopaque markers throw the ventricle by X-ray.

Also known as: Radiopaque markers method, Gastric scintigraphy
Diabetic dietDiet food in small particle size

Registered the gastric emptying after intervention. Comparing the registrations at the beginning and at the end of the study.

Also known as: motility, gastric emptying, improved gastric emptying
Diabetic dietDiet food in small particle size

Measure the blood glucose response and gastrointestinal symptoms after a test meal

Also known as: gastric emptying, plasma glucose response, metabolic control
Diabetic dietDiet food in small particle size

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diabetes type 1 or 2 and gastroparesis
  • must be able to understand oral and verbal instructions

You may not qualify if:

  • gastrointestinal surgery
  • other gastrointestinal disease
  • S-Creatinine \>150 umol/L
  • mental disease
  • cerebral disease
  • collagen disease
  • untreated endocrine disease
  • anticholinergic drugs
  • psychopharmacologic drugs
  • opiates
  • addiction to drugs as alcohol and narcotics
  • vegetarian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goteborg Universitet, Sahlgrenska Academy, Sahlgrenska University Hospital

Gothenburg, SE 413 45, Sweden

Location

Related Publications (1)

  • Olausson EA, Storsrud S, Grundin H, Isaksson M, Attvall S, Simren M. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol. 2014 Mar;109(3):375-85. doi: 10.1038/ajg.2013.453. Epub 2014 Jan 14.

MeSH Terms

Conditions

GastroparesisDiabetes Mellitus

Interventions

Quality of LifeNutritional StatusCell MovementGastric Emptying

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Health StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaPopulation CharacteristicsCell Physiological PhenomenaLocomotionMovementGastrointestinal MotilityDigestive System Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Magnus Simrén, M.D., Ph.D.

    Inst of Medicine, Sahlgrenska Academy, Göteborg University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2012

First Posted

March 19, 2012

Study Start

September 1, 2007

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

November 6, 2018

Record last verified: 2018-11

Locations